YIDU TECH Partners with First Affiliated Hospital of Nanchang University to Launch Two Health AI Agents for Emergency Training and Cardiovascular Education

Stock News08-03 14:33

YIDU TECH (02158) has announced a collaboration with the First Affiliated Hospital of Nanchang University (referred to as "the Hospital") to unveil two health-focused AI agents: an emergency teaching agent and a cardiovascular digital doctor agent named "Uncle Peng's Heart Vision." The latter is recognized as the first cardiovascular medicine AI agent for public education in China.

Both agents are built on the hospital's data and AI platforms, leveraging large language models' conversational and reasoning capabilities. Combined with the hospital's specialized knowledge base, they transform complex expertise in emergency medicine and cardiovascular health into accessible, easy-to-learn digital services. These tools aim to enhance medical education and public health management through intelligent support.

The launch event was hosted by Peng Xiaoping, a member of the Hospital's Party Committee. It was attended by notable figures including Pan Bingxing, Vice President of Nanchang University; representatives from the Jiangxi Provincial Department of Science and Technology and the Jiangxi Provincial Science and Technology Association; Liao Lan, Secretary of the Hospital's Party Committee; Li Jianming, Vice President of the Hospital; Huang Nan, Senior Vice President and General Manager of the Scientific Research Business Line at YIDU TECH; along with department heads, clinical experts, and corporate representatives.

Currently, the integration of AI with healthcare is breaking down barriers in medical education and health promotion. By utilizing large models, digital humans, and AI agents, standardizing medical training and popularizing chronic disease education have become key industry trends. These two agents target critical needs in healthcare: the emergency teaching agent is designed for medical students, practitioners, educators, and the public, offering support in knowledge explanation, scenario simulation, procedural guidance, case-based interaction, and intelligent Q&A. It covers scenarios such as cardiopulmonary resuscitation, AED usage, chest pain, stroke, airway obstruction, and common injuries, using tiered teaching, step-by-step practice, and real-time feedback to create a "teach, learn, practice, assess" model that improves teaching efficiency and emergency response skills.

The "Uncle Peng's Heart Vision" cardiovascular digital doctor agent is the first AI agent for cardiology public education in China. It relies on authoritative medical knowledge to provide accessible health information to the public and medical students. The agent focuses on common conditions like hypertension, coronary heart disease, arrhythmia, and heart failure, covering risk factors, lifestyle guidance, medication, and healthcare tips. It helps boost health awareness and medical literacy while assisting students in learning professional knowledge and improving communication skills.

Both agents are now available for free on the Hospital's WeChat public account and internet hospital platform, accessible to students, patients, and the public. This project extends the existing partnership between YIDU TECH and the Hospital, which previously involved building a comprehensive data platform and research platform. The latest collaboration delivers a medical AI middleware. According to Huang Nan, these agents exemplify a "clinical need-driven technology application" approach, using YIDU TECH's AI platform as a foundation to access the hospital's knowledge base, mitigate AI hallucinations through multiple checks, and enable rapid deployment of custom agents via low-code development. Additionally, YIDU TECH has integrated JD Health's digital human capabilities with the hospital's knowledge systems, achieving cross-ecosystem synergy.

YIDU TECH leverages its extensive experience in medical data governance, disease knowledge modeling, and vertical domain large language models to convert clinical expertise into machine-interpretable, executable intelligence. Its proprietary "AI Medical Brain," YiduCore, has processed and analyzed nearly 9 billion medical records, with a disease knowledge graph covering most known conditions. This core enables the agents to integrate medical knowledge, clinical pathways, and real-world data, delivering precise, safe, and continuous intelligent support through reasoning and multi-turn interactions.

Based on high-quality datasets and AI capabilities, YIDU TECH has developed a full-spectrum suite of AI agents for various healthcare scenarios. Through collaborations with top-tier hospitals, academicians, and experts, it has launched numerous specialized agents for areas like diagnosis assistance, treatment recommendations, and medical record generation. Its Copilot 2.0 platform alone hosts over 280 disease-specific agents across cardiology, oncology, and hematology, transforming experiential knowledge into evidence-based intelligent applications.

Huang Nan stated that the company will continue iterating these agents using its AI middleware, aiming to build personalized, full-cycle patient management systems aligned with the Hospital's development needs. Looking ahead, YIDU TECH plans to advance medical AI technologies, promoting standardized applications in education and health services to make reliable, understandable medical knowledge more accessible to healthcare professionals, students, and the public.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment